Gastric Motility Disorder - Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 40
Inquire Before Buying

Gastric Motility Disorder - Pipeline Review, H2 2012

Summary

Global Markets Direct's, 'Gastric Motility Disorder - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gastric Motility Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastric Motility Disorder. Gastric Motility Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gastric Motility Disorder.
- A review of the Gastric Motility Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Gastric Motility Disorder pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Gastric Motility Disorder.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Gastric Motility Disorder pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Gastric Motility Disorder - Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gastric Motility Disorder Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Gastric Motility Disorder 7
Gastric Motility Disorder Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Gastric Motility Disorder Therapeutics - Products under Development by Companies 14
Companies Involved in Gastric Motility Disorder Therapeutics Development 15
Theravance, Inc. 15
Helsinn Healthcare S.A. 16
Tranzyme Pharma, Inc. 17
Concert Pharmaceuticals, Inc. 18
Elixir Pharmaceuticals, Inc. 19
Gastric Motility Disorder - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
ulimorelin hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
TZP-102 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
EX-1314 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
velusetrag - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ipamorelin - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
TD-8954 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34
Gastric Motility Disorder - Product Development Milestones 38
Featured News & Press Releases 38
Jun 06, 2012: Tranzyme To Present Data On TZP-102 At American Diabetes Association Scientific Sessions 38
Jun 01, 2012: RaQualia Pharma Initiates First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Feb 29, 2012: RaQualia Pharma Receives MHRA Approval To Initiate First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40

List of Tables
Number of Products Under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Comparative Analysis by Late Stage Development, H2 2012 10
Comparative Analysis by Mid Clinical Stage Development, H2 2012 11
Comparative Analysis by Early Clinical Stage Development, H2 2012 12
Comparative Analysis by Pre-Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Theravance, Inc., H2 2012 15
Helsinn Healthcare S.A., H2 2012 16
Tranzyme Pharma, Inc., H2 2012 17
Concert Pharmaceuticals, Inc., H2 2012 18
Elixir Pharmaceuticals, Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34

List of Figures
Number of Products under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Late Stage Products, H2 2012 10
Mid Clinical Stage Products, H2 2012 11
Early Clinical Stage Products, H2 2012 12
Pre-Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

  • Ferulic Acid Market 2019 Forecasts Company Profile, Product Specifications & Capacity
    ‘Market Research Report on Global and Chinese Ferulic Acid (CAS 1135-24-6) Industry, 2009-2019’ is a top-notch market study report that delivers thorough understanding of market landscape and key-aspects of the ferulic acid industry. The research report systematically incorporates numerous elaborative sections and segments that aim at delivering most-accurate business statistics and premium industry insight to [...]
  • Overview of Global and Chinese 3D Printing Market 2015-2020
    ‘2015 3D Printing Industry Report -Global and Chinese Market’ is a comprehensive research report that describes the scope of the Global and Chinese 3D printing industry, analyzing the end-users behavior and the latest industry trends. Also, the report evaluates the growth prospects and the up-coming opportunities in the industry over the forecast period of 2015-2020. [...]
  • Schottky Diode Industry Research – 2015 Global and Chinese Market Overview
    ‘2015 Schottky Diode Industry Report – Global and Chinese Market Scenario’ is a top-notch research report, delivering premium industry insights and explanations of complex business scenarios. The report systematically articulates various growth prospects and current market challenges being faced by the existing industry players. The research report also drafts a meticulous business forecast that provides [...]
  • Codeine (CAS 76-57-3) Industry Research Report – 2009-2019 Market Forecast
    ‘Global and Chinese Codeine (CAS 76-57-3) Industry, 2009-2019 Market Research Report’, a systematically structured research report, that aims to deliver a detailed understanding of vivid market scenarios prevalent in the Codeine (CAS 76-57-3) industry to the user.  The report articulates various sections that thoroughly describe all key-aspects of the Codeine (CAS 76-57-3) industry. The report [...]
  • Global and Chinese Mainframe Banking Industry 2015 Outlook
    2015 Banks Mainframe Industry Report -Global and Chinese Market is a detailed market research report, delivering premium industry insights and analyzing the growth prospects of the industry over the forecast period of 2015-2020. The systematically structured sections of the research report, aims at conveying a strong business understanding to the user, enhancing the decision making [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Ulcerative Colitis - Pipeline Review, H2 2012
    Published: 31-Aug-2012        Price: US 2000 Onwards        Pages: 241
    Global Markets Direct’s, ''Ulcerative Colitis - Pipeline Review, H2 2012'', provides an overview of the Ulcerative Colitis therapeutic pipeline. This report provides information on the therapeutic development for Ulcerative Colitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ulcerative Colitis. ''Ulcerative Colitis - Pipeline Review, H2 2012'' is built using data and informati......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2012
    Published: 31-Aug-2012        Price: US 2000 Onwards        Pages: 159
    Global Markets Direct’s, ''Irritable Bowel Syndrome - Pipeline Review, H2 2012'', provides an overview of the Irritable Bowel Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Irritable Bowel Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Irritable Bowel Syndrome. ''Irritable Bowel Syndrome - Pipeline Review, H2 2012'' is ......
  • Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2012
    Published: 31-Aug-2012        Price: US 2000 Onwards        Pages: 45
    Global Markets Direct’s, ''Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2012'', provides an overview of the Functional (Non Ulcer) Dyspepsia therapeutic pipeline. This report provides information on the therapeutic development for Functional (Non Ulcer) Dyspepsia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Functional (Non Ulcer) Dyspepsia. ''Functional (Non Ulcer) Dy......
  • Other Gastrointestinal Disorders - Pipeline Review, H2 2012
    Published: 31-Aug-2012        Price: US 2000 Onwards        Pages: 52
    Global Markets Direct’s, ''Other Gastrointestinal Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Gastrointestinal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Gastrointestinal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Gastrointestinal Disorders. ''Other Gastrointestinal Di......
  • Peptic Ulcers - Pipeline Review, H2 2012
    Published: 31-Oct-2012        Price: US 2000 Onwards        Pages: 79
    Peptic Ulcers - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Peptic Ulcers - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Peptic Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peptic Ulcers. Peptic Ulcers - Pipeline Review, Half Year is built......
  • Gastroparesis - Pipeline Review, H2 2012
    Published: 31-Oct-2012        Price: US 2000 Onwards        Pages: 42
    Gastroparesis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Gastroparesis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gastroparesis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastroparesis. Gastroparesis - Pipeline Review, Half Year is built......
  • Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market
    Published: 01-Nov-2012        Price: US 3500 Onwards        Pages: 171
    GBI Research, the leading business intelligence provider, has released its latest research, "Gastrointestinal Disorders Therapeutics Market to 2018 Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market", which provides insights into the gastrointestinal disorders therapeutics market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-h......
  • Gastroenteritis - Pipeline Review, H2 2012
    Published: 28-Nov-2012        Price: US 2000 Onwards        Pages: 44
    Gastroenteritis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Gastroenteritis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gastroenteritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastroenteritis. Gastroenteritis - Pipeline Review, Half Yea......
  • Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2012
    Published: 28-Nov-2012        Price: US 2000 Onwards        Pages: 141
    Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gastrointestinal Stromal Tumor (GIST), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic developmen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs